Strategy for rational combinations of therapeutics to target resistant human myeloma cell lines. Collaborative Agreement Celgene and Prof Andrew Spencer and Dr Tiffany Khong.

  • Spencer, Andrew (Primary Chief Investigator (PCI))
  • Khong, Tiffany (Chief Investigator (CI))
  • Plowman, Chris (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date2/10/19 → 31/12/24

Keywords

  • Malignant Haematology